Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage
NCT01275794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1849
Last updated 2012-06-04
Summary
The purpose of the study is assessment of glycemic control and physicians satisfaction with results of DM2 OAD monotherapy
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Alexey Stepanov · AstraZeneca
Eligibility
- Min Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2011-03-31
- Completion
- 2011-03-31
Countries
- Russia
Study Locations
More Related Trials
-
A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
NCT04754334 ·Status: TERMINATED ·Phase: PHASE3
-
Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes
NCT01272804 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
NCT06579105 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
NCT00035984 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
NCT00495469 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers
NCT00933062 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Dapagliflozin Taken Twice-daily
NCT01217892 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
NCT01956305 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
NCT03244800 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects
NCT00937872 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea
NCT00995787 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus
NCT04889157 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM
NCT02581657 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
NCT00039013 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Type 2 Diabetes Treatment
NCT03164187 ·Status: COMPLETED
-
A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus
NCT00212641 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
NCT01240759 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus
NCT05596747 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)
NCT01217073 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186
NCT05694741 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients
NCT01396161 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses
NCT00841048 ·Status: COMPLETED ·Phase: PHASE1
-
A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin
NCT02053103 ·Status: TERMINATED ·Phase: PHASE2
-
A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects
NCT03061981 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
NCT05158244 ·Status: COMPLETED ·Phase: PHASE1